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22-27  May, 1999 
Biology of molecular chaperones, 
Acquafredda di Maratea, Italy. 
Contact: Dr Josip Hendekovie.  
Tel: +33 3 88 76 71 35 
Fax: -*33 3 88 36 69 
h ttp://www.es f.or~e uresco/ 
PC99121A.H'I 'M. 
30 May - 4 June, 1999 
Gordon research conference on 
immunochemistry & immunobiology, 
Barga, italy. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
West Kingston, RI 02892-0984, USA. 
e-nmil: app@grcmail.grc, uri.ed u 
h ttp://wwx~;gtc, u ri.ed t=/p rogra ms/1999/ 
immune.h im 
6-11 dune, 1999 
Gordon research conference on 
computational aspects of 
biomolecular NMR, EJarga, Italy. 
Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
West Kingston, RI 02892-0984, USA. 
Tel: +1 401 783 4011 
Fax: +1 401 783 7644 
e-mail: app@grcmail.grc.u ri.ed u 
http://wwwrowland.org/hoch/gre.html 
6-11 June, 1999 
Gordon research conference on 
second messengers and protein 
phosphorylation, Meriden, NH, USA. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PC) Box 984, 
West Kingston, RI 02892-0984, USA. 
Tel: +1 401 783 4011 
Fax: +1 401 783 7644 
e-mail: app@grcmail.grc.uri.edu 
http:/Iwww grc.uri.edu/progmms/19991 
second.him 
7-9  June, 1999 
High throughput screening -- the next 
generation, Guildford, U K. 
Contact: Conference Secretariat, Society 
of Chemical Industry, 14/15 Belgrave 
Square, London, SW1X 8PS, [-K. 
"1~1:+44 (0) 171 235 3681 
Fax: +44 (0) 171 235 7743 
e-mail: conferences@ehemind. 
demon.co.uk 
http://sci.mond.org/ 
13-17 June, 1999 
Gordon research conference on 
molecular and cell biology, Tilton, NH, 
USA. 
Contact: Gordon Research Conferences, 
tJniversiry of Rhode island, PO Box 984, 
West Kingston, RI 02892-0984, USA. 
Tel: +1 401 783 4011 
Fax: +1 401 783 7644 
e-mail: app@grcmail.grc.uri.ed u 
http://www.grc.uri.edulprograms[1999/ 
molcell .htm 
13-18  June, 1999 
Bioorganlc Gordon conference, 
Andover, NH, USA. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
x, Vcst Kingston, RI 02892-0984, USA. 
"lbl: +1 401 7834011 
l"ax: +1 401 783 7644 
e-mail: app@gremail.grc.u ri.edu 
h ttp://www.grc, u ri.e d u/program s/1999/ 
bioorgch.htm 
23-27  June, 1999 
RNA '99 -- Fourth annual meeting of 
the RNA society, Edinburgh, Scotland. 
Contact: The  RNA Societj, 9650 
Rockville Pike, Bethesda, MD 20814- 
3998, USA. 
Phone: +1 301 530 7120 
Fax: +1 301 530 7049 
e-mail: rna@faseb.org 
26dune - 1 July, 1999 
16th American peptide symposium, 
Minneapolis, MN, USA. 
Contact: .%laty Kay Ferguson, 
Administrative Assistant, 16th American 
Pept ide Symposium, c/o tJniversity of 
Minnesota, PO Box 64780, St Paul, 
Minnesota, F, IN 55164-0780, USA. 
"1~1: + 1 612 624 751)5 
c-mail: 16aps@chem.umn.edu 
h t tp: / /wwwchem.umn.edul l  6aps/ 
30 June - 1 July, 1999 
Combinatorial approaches to 
chemistry and biology !1, CambridGe , 
UK. 
Contact: Elaine V~'ellingham, 
Conference Secretariat, Bude Close, 
Nailsea, Bristol B.q48 2FQ, UK. 
"FeE +44 (0)1275 853311 
Fax: +44 (0)1275 853311 
v-mail: con fscc@dial.pip¢ x.com 
h ttp://www, rsc.orgs/cont~;, h tm 
4-9  July, 1999 
Gordon Research conference on 
purines, pyrimidines and related 
substances, Newport, RI, USA. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PO Box 984 
West Kingston, RI 02892-0984, USA. 
Tel: +1 401 7834011 
Fax: +1 401 783 7644 
e-mail: app@gremail.grc.uri.ed u 
http://wwx~:grc, nri.ed u/programs/ 
1999/purine.htm 
lO-15 July, 1999 
NMR in Molecular biology structure, 
binding and molecular recognition, 
Granada, Spain. 
Contact: Dr Josip Hendekovic.  
Tel: +33 3 88 76 71 35 
Fax: +33 3 88 36 69 87 
h ttp://www.es f.or~e uresco/ 
!,c99015a.htm 
11-15 July 1999 
RSC Perkln divlslon -- 2nd 
international conference: biological 
challenges for organic chemistry II, 
S Andrews, Fifo, UK. 
Cont'~ct: Nicola Durkan, The  Royal 
Society. of Chemistr5.; Conferences &
Divisional Affairs, Burlington House, 
London W1V 0B.N, UK. 
Tel: ÷ 44 (0)171 437 8656 
Fax: + 44 (0)171 734 1227 
e-mail conferences@rsc.org 
http://~v~:rsc.org/confercnccs 
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18-23 July, 1999 
Gordon Research conference on 
tissue engineering, biomaterials and 
biocompatibili~, Ho'.derness, NH, USA. 
Contact: Gordon Research Conferences, 
Lniversity of Rhode Island, PO Box 984, 
West Kingston, RI 02892-0984, USA. 
Tel: + 1 4(11 783 4011 
Fax: +1 401 783 7644 
e-mail: app@grcmail.grc.uri.ed u 
http://ww~:pittsburgh-tissue.nct/ 
broch ttre/Outreach/Gordon.h tml 
24-28 July, 1999 
13th Symposium of the protein 
society, Boston, MA, USA. 
Contact: The  Protein Socict'3' 
Symposium Office, 9650 Rockville Pike, 
Bethesda, Nil) 20814-3998, LISA. 
Tel: +1 301 5307010 
Fax +1 301 530 7014 
e-mail: prot99mtg@faseb.org 
http:/Iww'w f~seb.or~meetingsl 
proteir, cX)/ 
25-30 July, 1999 
Gordon Research conference on 
quantitative structure-activity 
relationships, Tilton, NH, USA. 
Cont:~ct: Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
YVest Kingston, RI 02892-0984, IiSA. 
Tel: +1 401 783 4011 
Fax: +1 401 783 7644 
e-maih app@grcmail.grc.uri.edu 
http://ww~:grc.uri.edulprograms/ 
1999/qsar.h tm 
8-13 August, 1999 
Gordon Research conference on 
matrix metalloproteinases, New 
London, NH, USA. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
West Kingston, RI 02892-0984, USA. 
'lie]: +1 401 7834011 
Fax: +1 401 783 7644 
e-maih app@grcmail.grc.uri.ed u 
h t tp://www.grc.uri.cdu/programs/1999/ 
marrix.htm 
14-19 August, 1999 
37th IUPAC Congress --frontiers in 
chemistry; molecular basis of the life 
sciences, Berlin, Germany. 
Contact: Professor l-]eindirck tom Dick, 
Gescllschaft Deutcher Chemikcr  -
IUPAC/GDCh99, PO Box 90 04 40, 
Frankfurt-am-iklain D 6(,~4~4, German3: 
"I~:1: + 49 69 7917 358 
Fax: + 49 69 7917 425 
e-mail: tg@gdch.dc 
15-20 August, 1999 
Gordon Research conference on 
biological structure and gene 
expression, Meriden, New Hampshire, 
USA. 
Contact: Gordon Research Conferences, 
University of Rhode Island, PO Box 984, 
West Kingston, R] 02892-0984, USA. 
qEl: + I 401 783 4011 
Fax: +1 401 783 7644 
e-maih app@grcmail.grc.u ri.ed u 
h ttp://www.grc.uri.edu/programs/1999/ 
biostruc.htm 
16-19 August, 1999 
Drug discovery technology, Boston, 
MA, USA. 
Contact: ..'klichael Keenan, IBC USA, 
225 Turnpike Road, Southboro, 
MA 01772, USA. 
Tel: +1 508 481 6400 
Fax: + 1 508 481 7911 
e-mail: mkeenan@ibcusa.com 
http://www ibcusa.comlusc22691 
22-26 August, 1999 
218th American Chemical society 
national meeting, New Orleans, USA. 
Contact: ACS, American Chemical 
Society Meetings Department,  1155 
Sixteenth Street, N.W. Washington, I)C 
20036 USA. 
"IEI: +1 202 872 4396 
Fax: + 1 202 872 6128 
e-maih natlmrgs@acs.org 
29 August - 4 September, 1999 
13th International congress on flavin 
and flavoproteins, University of 
Konstanz, Germany. 
Contact: Sandro Ghisla, Universit~t 
Konstanz, Fak. 13io]ogie _M644, D-78457 
Konstanz, Germany. 
'lbl: +49 7531 88 2291 
l:qx: +49 7531 88 4161 
h ttp://w~vw.u ni-konstanz.de/Fu /BiG/ 
tagnn~flavin.html 
e-maih Sandro.Ghisla@u ni-knnstanz.de 
5-7 September, 1999 
An international symposium on 
¢hirality, Csmbridge, UK. 
Contact: Dr Claire i)avc); Scientific 
Update, \Vyvern Cottage, I ligh Street, 
_Mayfield, East Sussex, ' rN20 6AE, I,K. 
Tel: +44 1435 873062 
Fax: +44 1435 872734 
e-maih sciup@scientificupdate.co.u k 
h t t p://ww~, scicn ti ficupda to.co, u k/ 
10-16 September, 1999 
lsoprenolds, 18th Conference, 
Prachatice, Czech Republic. 
(;ontact: Dr L Kohout, UOCHB As' C'R, 
Flemingovo 2, 166 10 Praha 6, Czech 
Republic. 
"li:l: +420 2 20183 200 
Fax: +420 2 24310090 
c-mail: kohout@uochb.cas.cz 
19-22 September, 1999 
3rd European symposium of the 
protein society, Garmisch-Partenkirchen, 
Germany 
Con;act: Third European Symposium of 
the Protein Society Meeting Office, 
9650 Rockville Pike, Bethesda, 
b id  20814-3998, USA 
Tel: +1 301 530 7010 
Fax: +1 301 530 7014 
e-maih europrot99@faseb.org 
www.fase b.orgJmee t in~europro99 
3-6 October, 1999 
International combinatorial chemistry 
symposium, Tuebingen, Germany 
(]ontact: Professor Gfinther Jung, 
Instltut ftir Organische Chemic, 
l.'niversltat ' l ' t ibingen, Auf der 
Nlorgenstelle 18, D-72076 Ti ib ingen, 
Germans: 
q~:l: +49 7071 29 76925 
Fax: +49 7071 29 5560 
e-maih gueathcr.jur, g@u ni-tuebingen.de 
h t tp://www.gdch, de/tagu ngJ1999/iccs/ 
index.htm 
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A selection of Interesting papers 
publ ished last month in Chemistry 
& Bio/ogys sister journals, Current 
Biology and Structure with Folding 
& Design, chosen and summarized 
by the staff of Chemistry & Biology. 
Chemistry & Biology May 1999, 
6:R152-R155 
© Elsevier Science Ltd ISSN 1074-5521 
[] Inhibitory phosphorylation of 
the APe  regulator Hct l  is 
controlled by the kinase Cdc28 
and the phosphatase Cdc14. 
Sue L Jaspersen, Julia F Charles and 
David O Morgan (1999). Curr. Biol. 
9, 227-236. 
Exit from mitosis requires inactivation 
of mitotic cycl in-dependent kinases 
(CDKs). A key mechanism of CDK 
inactivation is ubiquit in-mediated 
cyclin proteolysis, which is triggered by 
the late mitotic activation of a 
ubiquitin llgase known as the 
anaphase-promoting complex (APC). 
Activation of the APE; requires its 
Cdc5,15 ~ -- ? 
" ~ "  Cytokines;$ 
Anaphase I DNA ~repllCati~rl 
association with substoichiometric 
activating subunits termed Cdc20 and 
Hctl  (also known as Cdhl) .  Here, the 
authors explore the molecular function 
and regulation of the APC regulatory 
subunit Hct l  in Saccharonzrces cerevisiae, 
and conclude that Hct l  
phosphorylation is a key regulatory 
mechanism in the control of cyclin 
destruction. Phosphorylation of Hct l  
provides a mechanism by which Cdc28 
blocks its own inactivation during S 
phase and early mitosis, l,'ollowing 
anaphase, dcphosphorylation f Hct l  
by Cdc l4  may help initiate cyclin 
destruction. 
19 February 1999, Research Paper, 
Current Biology. 
Importance of the pleckstrin 
homology domain of dynamin in 
¢lathrin-mediated endocytosis. 
Yvonne Vallis, Patrick Wigge, Bruno 
Marks, Philip R Evans and Harvey T 
McMahon (1999). Curt. Biol. 
9, 257-260. 
The OTPase dynamin plays an 
essential role in clathrin-mediated 
endocytosis. Substantial evidence 
suggests that dynamin oligomerisation 
around the necks ofendocytosing 
vesicles and subsequent dynamin- 
catalysed GTP  hydrolysis is 
responsible for membrane fission. The  
pleckstrin homology (PH) domain of 
dynamin has previously been shown to 
BB 
BB 
interact with phosphoinositides, but it 
has not been determined whether this 
interaction is essential for dynamin's 
function in endocyrosis. In this stud% 
the authors address the in uivo function 
of the PH domain of dynamin by 
assaying the effects of deletions and 
point mutations in this region on 
transferrin uptake in COS-7 fibroblasts, 
and demonstrate that dynamin's 
interaction with phosphoinositides 
through its PH domain is essential for 
endocytosis. The  results also support 
the hypothesis that proline-rich 
domains (PRD)-SH3 domain 
interactions are'important in the 
recruitment of dynamin to sites of 
endocytosis. 
1 March 1999, Brief Communication, 
Current Biology. 
[] Dominant-negat ive inhibition of 
receptor-mediated endocytosis 
by a dynamin-1 mutant with a 
defective pleckstrin homology 
domain. 
Anthony Lee, David W Frank, Michae~ 
S Marks and Mark A Lemmon 
(1999). Curr. Biol. 9, 261-264. 
Ti le dynamlns are 100 kDa GTPases 
involved in the scission ofendocytic 
vesicles from the plasma membrane. 
Dynamin-I is present in solution as a 
tetramer, and undergoes further self- 
assembly following its recruitment to 
coated pits to tbrm higher-order 
oligomers that resemble 'collars' around 
the necks of nascent coated buds. GTP 
hydrolysis by dynamin in these collars is 
thought o accompany the 'pinching off" 
ofendocytic vesicles. Dynamin contains 
a pleckstrin homology (PH) domain that 
binds phosphoinositidcs, which in turn 
enhance both the GTPase activity and 
self-assembly of dynamin. The  attthors 
showed recently that the dynamin PH 
domain binds phosphoinositides only 
when it is oligomeric. 1lere, the authors 
demonstrate that interactions between 
the dynamin P} 1 domain and 
phosphoinositides are important for 
dynamin fimction in ui~ro, and propose 
that high-avidity binding to 
phosphoinositide-rich regions of the 
membrane by the multiple PH domains 
in a dynamin oligomer is critical for 
dynamin's ability to complete vesicle 
budding. 
1 March 1999, Brief Communication, 
Current Biology. 
[ ]  Simultaneous detection of 
multiple green fluorescent 
proteins in live cells by 
f luorescence l ifetime imaging 
microscopy. 
Rainer Pepperkok, Anthony Squire, 
Stephan Geley and Philippe IH 
Bastiaens (1999). Curr. Biol. 
9, 269-272. 
Suppl ied  by The British Library - "The wor ld 's  knowledge"  
Elsewhere in biology R153 
The green fluorescent protcin (GFP) 
has proven to be an excellent 
fluorescent marker for protein 
expression and Iocalisation in living 
cells. Several mutant GFPs with 
distinct fluorescence excitation and 
emission spectra have been engineered 
for intended use in muhilabell ing 
experiments. Discrimination of these 
co-expressed GFP variants by 
wavelength is hampered, however, by a 
high degree of spectral overlap, low 
quantum effieiencles and extinction 
coefficients, or rapid photobleaching. 
Using fluorescence lifetime imaging 
microscopy (FI.IM), four GFP variants 
were shown to have distinguishable 
fluorescence lifetimes. Among these 
0 1800 1,8 (ns) 3.8 
[0 2 s o o  1.s (ns) s.s i 
was a new variant (YFP5) with spectral 
characteristics reminiscent of yellow 
fluorescent protein and a comparatively 
long fluorescence lifetime. The  
fluorescence intensities of co-expressed 
spectra!ly similar GI 'P variants (either 
alone or as fusion proteins) were 
separated using lifetime images 
obtained with FI,I*,I at a single 
excitation wavelength and using a 
single broad band emission filter. 
Fluorescence lifetime imaging opens 
tip an additional spectroscopic 
dimension to wavelength through 
which novel GFP variants can be 
selected to extend the number of 
protein processes that can be imaged 
simuhaneously in cells. 
1 March 1999, Brief Communication, 
Current Biology. 
I-3 Movement of nuclear poly(A) 
RNA throughout he Inter- 
chromatin space in living cells. 
Joan C Politz, Richard A Tuft, Thoru 
Pederson and Robert H Singer 
(1999). Curt. BioL 9, 285-291. 
Messenger RN.& (mRNA) is transcribed 
and processed in the nucleus of 
eucaryotic ells and then exported to 
the cytoplasm through nuclear pores. It 
is not known whether the movement of 
mRNA from its site of synthesis to the 
nuclenr pore is directed or random. 
Directed movement would suggest that 
there is an energy-requiring step in 
addition to the step required for active 
transport through the pore, whereas 
random movement would indicate that 
mRNAs can make their way to the 
nuclear envelope by diffusion. The  
authors devised a method to visualize 
movemen t of endogenous polymcrase 
I1 transcripts in the nuclei of living 
cells. Oligo(dT) labelled with 
chemically masked (caged) fluorescein 
was allowed to penetrate ceils and 
hybridize to nuclear poly(A) RNA. 
Laser spot photolysis then uncaged the 
oligo(dT) at a given intranuclear site 
and the resultant fluorescent, 
hybridized oligo(dT) was tr~lcked using 
high-speed imaging microscopy. 
Poly(A) RNA moved away from the 
uncaging spot in all directions with a 
mean square displacement that varied 
linearly with time, and the same 
apparent diffusion coefficient was 
measured for the movement at both 
37°C and 23"C. These properties are 
characteristic of a random diffusive 
process. High-resolution three- 
dimensional imaging of llve cells 
containing both Hoechst-labelled 
chromosomes and uncaged oligo(dT) 
showed that, excluding nucleoli, the 
poty(A) RNA could access most, if not 
all, of  the nonchromosomal space in the 
nucleus. Poly(A) RNA can move freely 
throughout the interehromatin space of 
the nucleus with properties 
characteristic of diffusion. 
5 March 1999, Research Paper, 
Current Biology. 
I-; Structure of the vault, a 
ubiquitous cel lular component.  
Lawrence B Kong, Amara C Siva, 
Leonard H Rome, Phoebe L Stewart 
(1999). Structure 7, 371-379. 
The vault is a ubiquitous and highly 
conserved ribonucleoprorein particle of 
-13 MDa. 'This particle has been shown 
to he upregulated in certain multidrug- 
resistant cancer c ll lines and to share a 
protein component with the telomerase 
complex. Determination of the structure 
of the vault was undertaken to provide a 
first step towards understanding the role 
of this cellular component in normal 
metabolism and perhaps to shed some 
light on its role in mediating drug 
resistance. Over 1300 particle images 
were combined to calculate an -31/~. 
resolution structure of the vault. 
Rotational power spectra did not yield a 
clear symmetry peak, either because of 
the thin, smooth walls or inherent 
flexibility of the vault. The  authors' 
resuks reveal the vault to he a hollo~,; 
barrel-like structure with two protruding 
caps and an invaginated waist. Although 
the normal cellular function of the vault 
is as yet undetermined, the structure of 
the vault is consistent with either a role 
Suppl ied by The British Library - "The world's knowledge" 
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in subcellular transport, as previously 
suggested, or in seqt,esterlng 
macromolecular ssemblies. 
24 March 1999, Research Paper, 
Structure. 
[_] NMR structure of  the human 
oncofoeta l  f ibronect in  ED-B 
domaln ,  a specif ic  marker  for 
ang iogenes ls .  
Roberto Fattorusso, Maurizio 
Pellecchia, Francesca Viti, Paolo 
Neri, Dario Neri and Kurt WiJthrich 
(1999). Structure 7, ,381-890. 
The process of angiogenesis (i.e. the 
fbrmation of new blood vessels from pre- 
existing ones) is fundamental to 
physiological proccsscs uch as 
reproduction, development and repair, as 
well as to pathological conditions uch as 
tumor progression, rheumatoid arthritis 
and ocular disorders. The  oncofoetal 
ED-B domain, a specific marker of 
angiogenesis, consists of 91 amino-acid 
residues ~at  are inserted by alternative 
splicing into the fibronectin (FN) 
molecule. The  NMR structure of the 
ED-B domain is reported and reveals 
important differences from other FN 
type 111 domains. A comparison of the 
ED-B domain with the crystal structure 
of a four-domain FN fragment shows the 
novel features of ED-B to be located in 
loop regions that are buried at 
interdomain i terfaces, which therefore 
largely determine the global shape of the 
FN molecule. "Fhe negatively charged 
amino acids in this highly acidic protein 
arm uniformly distributed over the 
molecular st, trace, with the sole 
exception of a solvent-exposed 
hydrophohic patch that represents a 
potential specific recognition site. 
Epitope mapping with 82 decapeptides 
that span the ED-B sequence revealed 
that three ED-B-specifie monoclonal 
antibodies, which selectively target 
newly forming blood vessels in tumor- 
bearing mice, bind to adjacent regions on 
the ED-B surface. The  NMR structure 
enables the identification of a large 
surface area of the ED-B domain that 
appears to be accessible in vir,,o, opening 
up new dizgnostlc and therapeutic 
opportunities. Furthermore, the mapping 
of specific monoclonal antibodies to the 
three-dimensional structure of the ED-B 
domain, and their use in angiogcnesis 
inhibition experiments, provides a basis 
for further investigation of the role of the 
ED-B domain in the formation of new 
bloocl vessels. 
25 March 1999, Research Paper, 
Structure. 
The crystal structure of  
pyroglutamyl pept idase I f rom 
Bacillus amyloliquefaciens 
reveals a new structure for a 
cysteine protease.  
Y Odagaki, A Hayashi, K Okada, 
K Hirotsu, T Kabashima, KIto, 
T Yoshimoto, D Tsuru, M Sate 
and J Clardy (1999). Structure 7, 
399-419. 
The amino-terminal pyroglutamyl 
(pGlu) residue of peptidc hormones, 
such as thyrotropin-releasing hormone 
(TRH)  and luteinizing 
hormone releasing hormone (LH-RH),  
confers resistance to proteolysis by 
convcntional aminopeptidases. 
Specialized pyroglutamyl peptidases 
(PGPs) are able to cleave an amino- 
terminal pyroglutamyl residue and thus 
control hormonal signals. The  authors 
have determined the crystal structure of 
pyroglutamyl peptidase I (PGP-]) from 
Bacillus amyloliqnefaciens, the first 
strt,cture of argPGP. The  structure 
allows the function of most of the 
conserved residues in the PGP-I family 
to be identified. The  catalytic site has 
an SI pocket l ined with conserved 
hydrophobic residues to accommodate 
the pyroglutamyl residue. Aside from 
the SI pocket, there is no clearly 
defined mainchain substrate-binding 
region, consistent with the lack of 
substrate specificity. Although the 
overall structure of PGP-I  resembles 
some other ct/~ twisted open-sheet 
structures, such as purine nucleoside 
phosphorylase and cutinase, there arc 
important differences in the location 
and organization of the actlve-slte 
residues. ' l 'hus, PGP-I  belongs to a new 
family of cysteiae proteases. 
30 March 1999, Research Paper, 
Structure. 
[]  Crystal structure and funct ional  
character izat ion of  OmpK36,  the 
osmopor ln  of Klebslella 
pneumonlae. 
R Dutzler, G Rummel, S Atbertl, 
S Hern&ndez-AII6s, PS Phale, JP 
Rosenbusch, VJ Benedi and 
T Schirmer (1999). Structure 7, 
425-434. 
Porins are channel-forming membrane 
proteins that confer solute permeabilit.v 
to the outer membrane of Gram-ncgarlve 
bacteria. In Eschelit~ia toll, major 
nonspecific porlns are matrix porin 
(OmpF) and osmoporin (OmpC), which 
show high sequence homology,; In 
response to high osmolarity of the 
medium, OmpC is expressed at the 
expense of OmpF porin. Here, we study 
osmoporin of the pathogenic Klebsiella 
pr.eumoniae (OmpK36), which shares 879~ 
sequence identity with E. coli OmpC, in 
an attempt o establish why osmoporin is 
best sl,ited to function at high osmotic 
pressure. The  crystal structure of 
OmpK36 has been determined, and 
closely resembles that of the search 
model. The  homotrimerie structure is 
composed of three hollow 16-stranded 
antiparalle113 barrels, each delimiting a
separate pore. IX lost insertions and 
deletions with respect o OmpF are 
found in the loops that protrude towards 
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the cell exterior. Functiomdl.x; as 
characterized in lipid bilaycrs and 
llposomes, OmpK36 resembles Omp(] 
with decreased conductance and 
increased cation selectivity in 
comparison with OmpF. The  osmoporin 
structure suggests that an increase in 
charge density rather than an altered 
pore size is the basis for the distinct 
physicochemical properties of this porin 
that arc relevant for its preferential 
expression at high osmotic strength. 
31 March lOgO, Research Paper, 
Structure. 
[] Chloroplast NADP°malate 
dehydrogenase: structural basis 
of l ight-dependent regulation of 
activity by thiol oxidation and 
reduction. 
Paul D Cart, Denis Verger, Anthony 
R Ashton and David L Ollis (1999). 
Structure 7, 461-475. 
• "N'ADP-dependcnt malate 
dehydrogenase (EC 1.1.1.82) is a light- 
activated chloroplast enzyme that 
functions in the (24 pathway of 
photosynthesis. The  light regulation is 
believed to be mediated ipz taie..'o by 
thioredoxin-catalyzed r duction and re- 
oxidation ofcyst ine residt, es. The  rates 
of reversible activation and inactivation 
of the enzyme are strongly infh,enced 
by the coenzyme suhstrates that seem to 
ultimately determine the s~eady-state 
extent of activation i ~'ic, o. The core 
structure is homologous to NAD-  
dependent  malate dehydrogenases. "l\vo 
surface-exposed and thioredoxin- 
accessible disulfide bonds are present 
- -  one in the aaaino-terminal extension 
and the other in the carboxy-terminal 
extension. The  carboxy-terminal 
peptide of the inactive, oxidized 
enzyme is constrained by its disulfide 
bond to fold into the active site over 
NAI )P  +, hydrogen bonding to the 
catalytic His225, as well as obstructing 
access of the C a acid substmte. "lkvo 
loops flanking the active site, termed 
the Arg  z and 'l~'p loops, that contain the 
C 4 acid substratc binding residues are 
prevented from closing by the carboxy- 
terminal extension. The  structure 
explains the role of the carboxy-terminal 
extension in inhibit ing activity. The  
negative carboxyl terminus will interact 
more strongly with the positively 
charged nicotinamide of NADP"  than 
NADPI  1, explaining why the 
coenzyme-blndlng affinities of the 
enzyme differ so markedly from those of 
all other homologous ~-hydroxy acid 
dehydrogenases. NADP ÷ may also slow 
dissociation of the carboxyl terminus 
upon reduction, providing a mechanism 
for the inhibit ion of activation by 
NADP ÷ but not NADPH.  
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